Ovarian cancer management. Practice guidelines for nuclear physicians

Détails

ID Serval
serval:BIB_EEFDC7F26196
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Titre
Ovarian cancer management. Practice guidelines for nuclear physicians
Périodique
Quarterly Journal of Nuclear Medicine and Molecular Imaging
Auteur(s)
Classe  J. M., Fontanelli  R., Bischof-Delaloye  A., Chatal  J. F.
ISSN
1824-4785 (Print)
Statut éditorial
Publié
Date de publication
06/2004
Volume
48
Numéro
2
Pages
143-9
Notes
Journal Article
Review --- Old month value: Jun
Résumé
Ovarian cancer is a frequent and severe malignancy. Over 75% of cases are diagnosed at an advanced stage with disease spread beyond the ovaries. Despite the high response rates of initial treatments (i.e.,70-80%), the median progression-free survival of advanced ovarian cancer is 16-22 months, and the 5-year overall survival, 20-30%. The majority of these patients relapse, with metastatic peritoneal spread, unresectable, or drug resistant disease. Our goal was to outline current knowledge about diagnosis, prognostic factors, and treatments, and to dwell on non-nuclear medicine and nuclear-medicine diagnostic procedures.
Mots-clé
Female Humans Neoplasm Staging Ovarian Neoplasms/pathology/*radionuclide imaging/*therapy Prognosis Radioimmunodetection Tomography, Emission-Computed
Pubmed
Web of science
Création de la notice
25/01/2008 12:21
Dernière modification de la notice
03/03/2018 22:33
Données d'usage